AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Doxycycline Hydrochloride Equivalent To
13 registrations across 1 African market— 6 active
Markets with Doxycycline Hydrochloride Equivalent To
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DOXYMYCIN - 100 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Sept 2025 |
| CYCLIDOX EC 50 mg CAPSULES | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | suspended | Aug 2025 |
| CYCLIDOX EC 200 mg CAPSULES | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | suspended | Aug 2025 |
| CYCLIDOX EC 100 mg CAPSULES | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | suspended | Aug 2025 |
| DUMOXIN | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| DUMOXIN 50 CAPSULES | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| DORYX 50* | 🇿🇦South Africa | WARNER-LAMBERT SA (PTY) LTD | suspended | Jun 2022 |
| DOXYMYCIN - 50 CAPSULES | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| CYCLIDOX CAPSULES | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| DOXYCYL CAPSULES | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| DOXYCYL 100 | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| DOXYCLIN | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| DOXYMYCIN - 100 CAPSULES | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
Doxycycline Hydrochloride Equivalent To in Africa — Regulatory Overview
Doxycycline Hydrochloride Equivalent To is registered across 1 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 13 registrations, 6 (46%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.